2nd Quarter - Report

AMERICAN KIDNEY FUND for AMERICAN KIDNEY FUND

Firm
Client
Income
—
Expenses
$240,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Living Donor Protection Act (H.R. 2923 / S. 1384) Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 (H.R. 5027/S.4469) Honor Our Living Donors Act (H.R. 6020) Medigap Expansion Act Restore Protections for Dialysis Patients Act (H.R. 6860) Expressing support for the designation of the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day" (H.Res.1124) Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 (H.R. 5074, S. 4510) PASTEUR Act (H.R. 2940/S. 1355) Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2023 The Access to Genetic Counselor Services Act of 2023 (H.R. 3876/S. 2323) The CARING for Social Determinants Act of 2023 (H.R. 1066) End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model

LobbyistCovered position, as disclosed
HOLLY A. BODE —
DEBORAH DARCY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 4510 (118th), H.R. 1066 (118th), H.Res. 1124 (118th), H.R. 2940 (118th), S. 2323 (118th), S. 1355 (118th), H.R. 6020 (118th), H.R. 2923 (118th), H.R. 5027 (118th), H.R. 3876 (118th), S. 1384 (118th), S. 4469 (118th), H.R. 5074 (118th), H.R. 6860 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.